Overall rank by patents
#25,636
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01M (TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR).
The verdict
Acellent holds 10 US patents across 5 technology areas, rank #25,636 of 50,000 tracked assignees.
Acellent Technologies, Inc. has been granted 10 US utility patents between 2015 and 2023, placing Acellent Technologies, Inc. at rank #25,636 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in G01M (TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR). As a US Corporation, Acellent Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Acellent sits between Absolics Inc. (10 patents, rank #25,632) and Actimed Therapeutics Limited (10 patents, rank #25,640) - the closest US assignees by grant volume. The composite Innovation Score of 25.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 5 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Acellent Technologies, Inc.'s 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Acellent Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ABSOLICS INC.
10 patents
ACCIONA ENERGIA S.A.
10 patents
ACCORD IDEATION PRIVATE LIMITED
10 patents
ACEA Therapeutics, Inc.
10 patents
ACESSA HEALTH INC.
10 patents
ACME Furniture Industry, Inc.
10 patents
ACR ELECTRONICS, INC.
10 patents
ACTIMED THERAPEUTICS LIMITED
10 patents
ACELLENT TECHNOLOGIES, INC.
10 patents
What this shows Acellent holds 10 patents at rank #25,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Acellent's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
26 Top 81% higher than 19% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2017 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 2 | 20.0% |
| 2021 | 2 | 20.0% |
| 2023 | 1 | 10.0% |
Top 5 of 5 technology areas
Overall rank by patents
#25,636
Across all tracked assignees
25.9 out of 100
How to use this portfolio
Acellent's 10 grants land it in the top 81% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.